Covered recipient · General Payments record
RAHUL IYENGAR
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2021–2024
$3,927.68
- Reported across 46 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,004.51 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $325.70 | 11 |
| Apellis Pharmaceuticals, Inc. | $190.14 | 2 |
| Dutch Ophthalmic, USA | $174.51 | 1 |
| Alcon Laboratories Inc | $168.91 | 2 |
| Astellas Pharma US Inc | $121.81 | 1 |
| Genentech USA, Inc. | $23.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.26 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103974808 | CMS |
| ABBVIE INC. | $32.05 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103974810 | CMS |
| ABBVIE INC. | $26.98 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103974812 | CMS |
| ABBVIE INC. | $30.40 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103974814 | CMS |
| ABBVIE INC. | $23.83 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103974816 | CMS |
| ABBVIE INC. | $6.44 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103974818 | CMS |
| ABBVIE INC. | $11.51 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103974820 | CMS |
| ABBVIE INC. | $124.20 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103974822 | CMS |
| ABBVIE INC. | $20.19 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103974824 | CMS |
| ABBVIE INC. | $8.26 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103974826 | CMS |
| ABBVIE INC. | $16.58 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103974828 | CMS |
| Alcon Vision LLC | $141.89 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110700656 | CMS |
| Alcon Vision LLC | $27.02 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110700654 | CMS |
| Apellis Pharmaceuticals, Inc. | $123.67 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154027941 | CMS |
| Apellis Pharmaceuticals, Inc. | $66.47 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154027939 | CMS |
| Astellas Pharma US Inc | $121.81 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139414373 | CMS |
| Dutch Ophthalmic, USA | $174.51 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154792530 | CMS |
| Genentech USA, Inc. | $23.44 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133091811 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.